Commonwealth of Pennsylvania Public School Empls Retrmt SYS Boosts Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 25.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 175,317 shares of the real estate investment trust’s stock after purchasing an additional 35,714 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Sabra Healthcare REIT were worth $3,371,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in SBRA. Rothschild Investment LLC grew its stake in shares of Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 889 shares during the period. Smartleaf Asset Management LLC lifted its stake in shares of Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares during the period. Strengthening Families & Communities LLC purchased a new stake in Sabra Healthcare REIT during the fourth quarter worth about $29,000. Danske Bank A S purchased a new stake in Sabra Healthcare REIT during the third quarter worth about $30,000. Finally, Larson Financial Group LLC grew its position in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 553 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ:SBRA opened at $19.52 on Thursday. The business’s fifty day moving average price is $19.62 and its two-hundred day moving average price is $19.73. The stock has a market cap of $4.92 billion, a PE ratio of 30.98, a price-to-earnings-growth ratio of 1.47 and a beta of 0.65. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. Sabra Healthcare REIT, Inc. has a one year low of $17.17 and a one year high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.16. The business had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business’s revenue was up 20.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, analysts forecast that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.1%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

Wall Street Analysts Forecast Growth

SBRA has been the subject of a number of research analyst reports. Citigroup cut shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and dropped their target price for the company from $24.00 to $19.00 in a report on Monday, June 22nd. Wells Fargo & Company boosted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Raymond James Financial began coverage on Sabra Healthcare REIT in a research note on Wednesday, June 17th. They issued an “underperform” rating for the company. Finally, Cantor Fitzgerald lifted their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Five research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Sabra Healthcare REIT presently has an average rating of “Hold” and an average price target of $21.45.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.